Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Jefferies

The war for your teeth

Millions of dollars in legal bills and aggressive marketing have piled up.

Axios

Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022

Upgrades See all analyst ratings upgrades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022

Upgrades

Benzinga

A new work anxiety: Will I be penalized for working from home?

In the "new normal" of the hybrid workplace, are remote and in-person workers going to be treated equally? It's a matter of hot debate right now.

WEKU

Climate change, scarcity chip away at degrowth taboo

Degrowth - the idea that a finite planet cannot sustain ever-increasing consumption - is about the closest you can get to a heresy in economics, where growth is widely held as the best route to prosperity.

Reuters

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022

Upgrades

Benzinga

Jefferies Maintains Hold Rating for Douglas Emmett: Here's What You Need To Know

Jefferies has decided to maintain its Hold rating of Douglas Emmett (NYSE:DEI) and lower its price target from $31.00 to $24.00. Shares of Douglas Emmett are trading down 1.04% over the last 24 hours, at $22.32 per share. A move to $24.00 would account for a 7.5% increase from the…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022

Upgrades

Benzinga

Xenon Pharmaceuticals Shares Drop On Proposed Public Offering

Xenon Pharmaceuticals Inc (NASDAQ:XENE) announced an underwritten public offering of its common shares. Underwriters of the offering will be granted an option for a period of 30 days to purchase an additional 15% of common shares at the public offering price. Jefferies, J.P. Morgan, SVB Securities, and Stifel are acting as joint…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Microsoft Whale Trades For June 17

Someone with a lot of money to spend has taken a bearish stance on Microsoft (NASDAQ:MSFT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Jefferies Maintains Buy Rating for Outbrain: Here's What You Need To Know

Jefferies has decided to maintain its Buy rating of Outbrain (NASDAQ:OB) and lower its price target from $9.00 to $8.00. Shares of Outbrain are trading down 14.48% over the last 24 hours, at $4.75 per share. A move to $8.00 would account for a 68.24% increase from the current share…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022

Upgrades

Benzinga

Tapestry — Owner Of Fashion Brand Coach — Is A "Structural Pandemic Winner," Jefferies Says In Upgrade: What Else Impressed This Analyst?

Tapestry Inc (NYSE: TPR) has been through a culture change focusing on data-driven results, which should continue to drive progress, according to Jefferies.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Microsoft Whale Trades Spotted

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2022

Upgrades

Benzinga

10 Biggest Price Target Changes For Wednesday

Jefferies raised Tapestry, Inc. (NYSE: TPR) price target from $30 to $45. Tapestry shares rose 2.2% to close at $31.60 on Tuesday.

Benzinga

Jefferies Maintains Buy Rating for SVB Finl Gr: Here's What You Need To Know

Jefferies has decided to maintain its Buy rating of SVB Finl Gr (NASDAQ:SIVB) and lower its price target from $692.00 to $534.00. Shares of SVB Finl Gr are trading down 7.14% over the last 24 hours, at $411.27 per share. A move to $534.00 would account for a 29.84% increase…

Reuters

Age to buy cigarettes in England should rise every year, review says

The legal age of sale for cigarettes in England should be raised by one year every year until eventually no one can buy tobacco products, a government-commissioned review said on Thursday.

Benzinga

79 Biggest Movers From Yesterday

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.

Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma Delta T cell allogeneic therapies.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.